NathanColemanNussbaumMD

PubMed

• 85 citations
  Validation analysis of a composite real-world mortality endpoint for patients with cancer in the United States.
  Qianyi Zhang, Anala Gossai, Shirley Monroe, Nathan C. Nussbaum, Christina M. Parrinello> ;Health Services Research. 2021 May 17
• 20 citations
  Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC
  Xinran Ma, Lawrence Bellomo, Kelly Magee, Caroline S. Bennette, Olga Tymejczyk, Meghna Samant, Melisa Tucker, Nathan C. Nussbaum, Bryan Bowser, Joshua S. Kraut, Ariel ...> ;Advances in Therapy. 2021 Mar 5
• 18 citations
  Validation of diagnosis codes to identify side of colon in an electronic health record registry.
  Patricia Luhn, Deborah Kuk, Gillis Carrigan, Nathan C. Nussbaum, Rachael Sorg, Rebecca Rohrer, Melisa Tucker, Brandon Arnieri, Michael Taylor, Neal J. Meropol> ;BMC Medical Research Methodology. 2019 Aug 19
• 327 citations
  Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database
  Gaurav Singal, Peter Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M. Frampton, Aracelis Z. Torres, Erik M. Lehnert, Da...> ;JAMA. 2019 Apr 9
• 6 citations
  Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer.
  Fauzia Riaz, Carolyn J Presley, Anne C. Chiang, Janina A. Longtine, Pamela R. Soulos, Kerin B. Adelson, Roy S. Herbst, Nathan C. Nussbaum, Rachael Sorg, Amy P. Abernet...> ;Journal of Geriatric Oncology. 2019 Feb 2
• 42 citations
  An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer
  Alexander Liede, Rohini K. Hernandez, Sally W. Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth> ;Oncoimmunology. 2018 Sep 5
• 97 citations
  Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
  Carolyn J Presley, Daiwei Tang, Pamela R. Soulos, Anne C. Chiang, Janina A. Longtine, Kerin B. Adelson, Roy S. Herbst, Weiwei Zhu, Nathan C. Nussbaum, Rachael Sorg, Vi...> ;JAMA. 2018 Aug 7
• 82 citations
  Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
  Jeremy M. O’Connor, Kristen L Fessele, Jean Steiner, Kathi Seidl-Rathkopf, Kenneth R. Carson, Nathan C. Nussbaum, Emily S. Yin, Kerin B. Adelson, Carolyn J Presley, An...> ;JAMA Oncology. 2018 Aug 1
• 81 citations
  Characteristics of Real‐World Metastatic Non‐Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval
  Sean Khozin, Amy P. Abernethy, Nathan C. Nussbaum, Jizu Zhi, Melissa D. Curtis, Melisa Tucker, Shannon E. Lee, David E. Light, Anala Gossai, Rachael Sorg, Aracelis Z. ...> ;The Oncologist. 2018 Mar 1
• 14 citations
  The neoadjuvant treatment of rectal cancer: a review.
  Nathan C. Nussbaum, Ivy Altomare> ;Current Oncology Reports. 2015 Feb 19
• Join now to see all